AELMHU and FEDER launch FollowER to ensure the transition of pediatric care to adult care in rare diseases

AELMHU and FEDER launch FollowER to ensure a planned transition of pediatric care to adulthood in rare diseases.

Add DEMÓCRATA to Google

Ask FREN

Published

2 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 18 de noviembre de 2026 · 17 institutos

  • PP31,4 %
  • PSOE27,4 %
  • Vox19,0 %
  • Frente Amplio6,1 %
  • ERC2,4 %
  • SALF2,0 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

The Spanish Association of Laboratories of Orphan and Ultra-Orphan Medicines (AELMHU) and the Spanish Federation of Rare Diseases (FEDER) have launched FollowER, an initiative aimed at optimizing the transition from pediatric care to adult care in people with rare diseases. The project seeks to design a care model proposal that guarantees continuity of care and strengthens coordination among the different healthcare professionals involved.

"In rare diseases, ensuring continuity of care is as important as advancing in diagnosis and access to treatments. Reaching adulthood cannot entail a rupture in care or a loss of the accumulated knowledge about each patient," says Clara Foyaca, member of the Board of Directors of AELMHU.

The transition to adulthood usually involves a change of medical teams, specialists, and reference professionals, which can lead to coordination problems and gaps in clinical follow-up and treatments, "in a context in which the experience and knowledge accumulated about each patient are fundamental."

One of the great challenges is to move toward homogeneous criteria that help reduce disparities in care among healthcare centers and autonomous communities, while at the same time respecting the needs and reality of each person. "With FollowER we want to contribute to promoting a planned and coordinated process, which allows responding to their needs at each stage of life," it states.

Comprehensive transition model and multidisciplinary work

The initiative provides for the development of a reference document that includes a proposal for an integrated model of care transition, based on an analysis of the current situation and the identification of the main needs of people with rare diseases.

To this end, it will rely on a multidisciplinary Technical Committee and a work plan that will include interviews with healthcare professionals, surveys, and meetings with experts, with the purpose of integrating different care perspectives and pathways in formulating the proposal.

The ultimate goal is to define recommendations and practical guidelines that can serve as a guide for health professionals and help improve care for people with rare diseases across the National Health System.

The project brings together institutions, healthcare professionals and patients, and also includes, within the Institutional Committee, the participation of the Ministry of Health. This cooperation will facilitate the incorporation of diverse clinical, care and social perspectives to shape a robust proposal that is tailored to the reality of those who live with rare diseases.

Among the participating entities are: Asociación Española de Pediatría (AEP), Plataforma de Organizaciones de Pacientes (POP), Sociedad Española de Calidad Asistencial (SECA), Sociedad Española de Directivos de la Salud (SEDISA), Sociedad Española de Farmacia Hospitalaria (SEFH), Sociedad Española de Medicina Familiar y Comunitaria (semFYC), Sociedad Española de Medicina Interna (SEMI), Sociedad Española de Médicos de Atención Primaria (SEMERGEN) and Sociedad Española de Médicos Generales y de Familia (SEMG).